Last Updated : July 9, 2010
Details
FilesGeneric Name:
Paliperidone palmitate
Project Status:
Complete
Therapeutic Area:
Schizophrenia
Manufacturer:
Janssen-Ortho Inc.
Call for patient/clinician input open:
Brand Name:
Invega Sustenna
Project Line:
Reimbursement Review
Project Number:
SR0206-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Schizophrenia
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : July 9, 2010